Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1995-06-06
2009-12-01
Parkin, Jeffrey S. (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C424S208100, C435S325000
Reexamination Certificate
active
07626013
ABSTRACT:
The inventors have isolated cloned cDNA encoding the RNA genome of Human Immunodeficiency Virus type 1 (HIV-1). Various clones are described, which encode different regions of the genome, including those regions encoding viral antigens or proteins. Hybridization results indicate the difference between the HIV-1 clones and those of HTLV-I and HTLV-II. The inventors have also produced a restriction map of the entire cloned genomic sequence in order to facilitate further subcloning and using the restriction fragments in other hybridization tests and in methods to express encoded sequences.
REFERENCES:
patent: 4520113 (1985-05-01), Gallo et al.
patent: 4629783 (1986-12-01), Cosand
patent: 4661445 (1987-04-01), Saxinger et al.
patent: 4708818 (1987-11-01), Montagnier et al.
patent: 4716102 (1987-12-01), Levy
patent: 4725669 (1988-02-01), Essex et al.
patent: 5135864 (1992-08-01), Montagnier et al.
patent: 5156949 (1992-10-01), Luciw et al.
patent: 0 173 529 (1985-08-01), None
patent: 0 199 301 (1986-10-01), None
patent: 0 230 784 (1987-08-01), None
patent: 0 249 390 (1987-12-01), None
patent: 0 249 394 (1987-12-01), None
patent: WO 85/04903 (1985-11-01), None
patent: WO 86/01535 (1986-05-01), None
Arya et al., 1984, Science 225:927-930.
Wain-Hobson et al., 1985, Cell 40:9-17.
Holland et al., Curr. Topics Micro. Immunol. 176:1-19, 1992.
Goodenow et al., J. Acquir. Immune Defic. Syndr. 2:344-352.
Gao et al., J. Virol. 68:7433-7447.
Holland, J.J., et al., 1992, “RNA Virus Populations as Quasispecies”, Curr. Topics Microbiol. Immunol. 176:1-20.
Goodenow, M., et al., 1989, “HIV-1 Isolates Are Rapidly Evolving Quasispecies: Evidence for Viral Mixtures and Preferred Nucleotide Substitutions”, J. Acquir. Immune Defic. Syndr. 2:344-352.
Gao, F., et al., 1994, “Genetic Diversity of Human Immunodeficiency Virus Type 2: Evidence for Distinct Sequence Subtypes with Differences in Virus Biology”, J. Virol. 68(11):7433-7447.
Gelmann, E.P. et al., “Molecular Cloning of a Unique Human T-cell Leukemia Virus (HTLV-IIMo)”, Proc. Natl. Acad. Sci., 81, 993-997 (1984).
Barre-Sinoussi, F. et al., Isolation of A T-Lymphotropic Retrovirus From a Patient at Risk For Acquired Immune Deficiency Syndrome (AIDS) Science, 220, 868-871, (1983).
Alizon, et al., “Molecular Cloning of Lymphadenopathy-Associated Virus”, Nature, 312, 757-760.
Gelmann et al, “Proviral DNA of a Retrovirus, Human T-Cell Leukemia Virus, in Two Patients with AIDS”, Science, 220, 862-865 (1983).
Hahn et al., “Molecular Cloning and Characterization of the HTLV-III Virus Associated with AIDS”, Nature 312, 166-169, (1984).
Shaw et al., “Molecular Characterization of Human T-Cell Leukimia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome”, Science, 226, 1165-1171, (1984).
Kalyanaraman et al., “Antibodies to the Core Protein of Lymphadenopathy Associated Virus (LAV) in Patients With AIDS”, Science, 225, 321-323, (1984).
Scheupbach et al., “Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS”, Science 224, 503-505, (1984).
Sarngadharan et al., “Antibodies reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS”, Science 224 506-508, 1984.
Montagnier, “Adapation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines”, Science, 225, 63-66, (1984).
Chang et al., “Expression inEscherichia coliof Open Reading Frame Gene Segments of HTLV-III”, Science, 228, 93-96, 1985.
Chang et al., “An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS”, Nature, 315, 151-154 1985.
Ratner et al., “Complete Nucleotide Sequence of the AIDS Virus, HTLV-III” Nature vol. 313, 277-283, 1985.
Safai et al., “Seroepidemiological Studies of Human T-Lymphotropic Retrovirus Type III in Acquired Immunodeficiency Syndrome”, The Lancet, 1438-1440, 1984.
Alizon Marc
Barre Sinoussi Francoise
Chermann Jean-Claude
Montagnier Luc
Sonigo Pierre
Centre National de la Recherche Scientifique
Finnegan Henderson Farabow Garrett & Dunner LLP
Institut-Pasteur
Parkin Jeffrey S.
LandOfFree
HIV-1 DNA fragments that hybridize to genomic HIV-1DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV-1 DNA fragments that hybridize to genomic HIV-1DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV-1 DNA fragments that hybridize to genomic HIV-1DNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4058890